Treatment of adenocarcinoma of the pancreas with somatostatin and gonadoliberin (luteinizing hormone-releasing hormone). The French Associations for Surgical Research. [electronic resource]
Producer: 19921029Description: 348-53 p. digitalISSN:- 0002-9610
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Clinical Protocols
- Female
- Gonadotropin-Releasing Hormone -- administration & dosage
- Humans
- Lymphatic Metastasis
- Male
- Middle Aged
- Pancreatic Neoplasms -- drug therapy
- Prospective Studies
- Remission Induction
- Somatostatin -- administration & dosage
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.